Book a demo.Please fill out the form below and we will contact you shortly to schedule your demo.
|
|
Our founder & CEO: Douglas Selinger, Ph.D.

As an early pioneer of microarray technology, Douglas authored some of the first publications describing experimental and computational approaches for large scale transcriptional analyses. After completing his Ph.D. in George Church’s lab at Harvard, he joined the Novartis Institutes for Biomedical Research where his 14-year career spanned the entire drug discovery process, including significant work in target ID/validation, high throughput screening, and preclinical safety.
In 2017, Douglas founded Plex Research to develop a novel form of AI based on search engine algorithms. Plex’s unique platform has helped dozens of biotech and pharma companies accelerate their drug discovery pipelines by providing interpretable and actionable analyses of massive chemical biology and omics data sets.
In 2017, Douglas founded Plex Research to develop a novel form of AI based on search engine algorithms. Plex’s unique platform has helped dozens of biotech and pharma companies accelerate their drug discovery pipelines by providing interpretable and actionable analyses of massive chemical biology and omics data sets.
Our office.
Plex is located in Central Square, Cambridge, MA – halfway between Harvard and MIT, in the middle of a well-known international hub for biomedical and pharmaceutical research.